INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $230,380 | +3.9% | 451,725 | -20.8% | 0.17% | -2.4% |
| Q3 2023 | $221,749 | +172.4% | 570,049 | +212.7% | 0.17% | +220.8% |
| Q2 2023 | $81,396 | -32.2% | 182,297 | +24.6% | 0.05% | -36.9% |
| Q1 2023 | $119,966 | -47.6% | 146,300 | -0.5% | 0.08% | -55.8% |
| Q4 2022 | $229,000 | -9.8% | 147,075 | -0.2% | 0.19% | -11.6% |
| Q3 2022 | $254,000 | +12.4% | 147,380 | +12.8% | 0.22% | +313.5% |
| Q2 2022 | $226,000 | -20.4% | 130,601 | +64.9% | 0.05% | -72.9% |
| Q1 2022 | $284,000 | -21.8% | 79,182 | +9.0% | 0.19% | -21.6% |
| Q4 2021 | $363,000 | -22.3% | 72,647 | +11.5% | 0.24% | -23.9% |
| Q3 2021 | $467,000 | -19.5% | 65,168 | +4.2% | 0.32% | -18.5% |
| Q2 2021 | $580,000 | – | 62,566 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |